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Abstract
Background: Whole-exome sequencing (WES) over the last few years has been increasingly employed for clinical
diagnosis. However, one caveat with its use is that it inevitably fails to detect disease-causative variants that occur
within noncoding RNA genes. Our experience in identifying pathogenic variants in the noncoding RNU4ATAC gene,
in a Chinese family where two successive foetuses had been affected by severe microcephaly, is a case in point.
These foetuses exhibited remarkably similar phenotypes in terms of their microcephaly and brain abnormalities;
however, the paucity of other characteristic phenotypic features had made a precise diagnosis impossible. Given
that no external causative factors had been reported/identified during the pregnancies, we sought a genetic cause
for the phenotype in the proband, the second affected foetus.
Results: A search for chromosomal abnormalities and pathogenic copy number variants proved negative. WES was
also negative. These initial failures prompted us to consider the potential role of RNU4ATAC, a noncoding gene
implicated in microcephalic osteodysplastic primordial dwarfism type-1 (MOPD1), a severe autosomal recessive
disease characterised by dwarfism, severe microcephaly and neurological abnormalities. Subsequent targeted
sequencing of RNU4ATAC resulted in the identification of compound heterozygous variants, one being the most
frequently reported MOPD1-causative mutation (51G>A), whereas the other was a novel 29T>A variant. Four
distinct lines of evidence (allele frequency in normal populations, evolutionary conservation of the affected nucleotide,
occurrence within a known mutational hotspot for MOPD1-causative variants and predicted effect on RNA secondary
structure) allowed us to conclude that 29T>A is a new causative variant for MOPD1.
Conclusions: Our findings highlight the limitations of WES in failing to detect variants within noncoding RNA genes
and provide support for a role for whole-genome sequencing as a first-tier genetic test in paediatric medicine.
Additionally, the identification of a novel RNU4ATAC variant within the mutational hotspot for MOPD1-causative variants
further strengthens the critical role of the 5′ stem-loop structure of U4atac in health and disease. Finally, this analysis
enabled us to provide prenatal diagnosis and genetic counselling for the mother’s third pregnancy, the first report of
its kind in the context of inherited RNU4ATAC variants.
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Background
Microcephaly is usually defined in terms of a head cir-
cumference more than two standard deviations below
the mean for age and sex; it can occur in the womb or
may develop during the first few years of life [1, 2]. Ab-
normal growth of the head may occur as a consequence
of a number of factors, both genetic and environmental
(e.g. exposure to certain viruses such as rubella, drugs
and alcohol during pregnancy) [3]. The genetic causes
are highly heterogeneous; thus, a search for microceph-
aly in the Human Phenotype Ontology database [4]
yielded 652 genes. Depending on the precise nature of
the condition involved, microcephaly may be associated
with seizures, developmental delay, intellectual disability
or other problems. It may even be associated with sub-
stantial physical disability and premature death; there is
no treatment for microcephaly. Therefore, it is extremely
important to identify the genetic causes of severe micro-
cephaly in affected families with a view to providing pre-
natal diagnosis and genetic counselling in subsequent
pregnancies.
With the decreased cost of next-generation sequen-
cing, whole-exome sequencing (WES) has rapidly
evolved from its original application as a tool for gene
discovery in research settings to an important diagnostic
tool in a clinical context [5–7], especially for diseases
that are characterised by a significant level of genetic
heterogeneity [8]. However, one caveat with WES is that
disease-causative variants which occur within noncoding
RNA genes will invariably be missed [9, 10]. Here, we
highlight this issue by describing our experience of iden-
tifying novel compound heterozygous variants in the
noncoding RNU4ATAC gene (OMIM #601428), in a
Chinese family with two successive foetuses affected by
severe microcephaly.
Results
Family description
A 30-year-old woman was referred to our centre at the
First Affiliated Hospital of Sun Yat-Sen University after
her second foetus (II:2) had been found to have severe
microcephaly at 24 gestational weeks (GW), just as her
first one (II:1; Fig. 1a) had previously. Clinical findings in
the two affected foetuses, who were terminated at 36
GW (II:1) and 30 GW (II:2) respectively, are illustrated
in Fig. 2 and summarised in Table 1. However, no pre-
cise diagnosis of the underlying abnormality could be
made based upon these clinical findings owing to the
paucity of characteristic features beyond severe micro-
cephaly. In the case of II:1, standard G-banding karyo-
typing using cord blood cells taken at 35 GW revealed a
normal karyotype, whereas chromosomal microarray
analysis failed to detect any pathogenic copy number
variations; no further analyses were performed at the
time.
The parents were of North Chinese origin, healthy and
nonconsanguineous. Exposure to known causative envir-
onmental factors during pregnancy was neither reported
nor identified. Taken together with the remarkably simi-
lar clinical phenotypes in the two affected foetuses
(Fig. 2; Table 1), a genetic cause was considered to be
likely. An extensive molecular genetic analysis was
therefore performed on foetus II:2.
Extensive karyotyping and chromosomal microarray
analysis failed to identify any chromosomal abnormality
or pathogenic copy number variations in II:2
We first performed standard G-banding karyotyping
using cord blood cells from II:2 (taken at 29 GW), but
no chromosomal abnormalities were found. In the
meantime, we also performed chromosomal microarray
analysis using genomic DNA prepared from the cord
blood cells taken from II:2. No pathogenic copy number
variants were identified by reference to data available in
OMIM [11], DGV [12] and DECIPHER [13].
WES also failed to reveal a genetic cause of the
microcephaly in II:2
We further employed WES to search for putative causal
variants in an unbiased and hypothesis-free manner. The
resulting single-nucleotide variants (SNVs) and small in-
sertions or deletions (indels) were subjected to the fol-
lowing prioritizations: (i) variants that cause non-
synonymous, frameshift and in-frame changes and vari-
ants that occurred at splice sites; (ii) variants with a
minor allele frequency of less than 5% according to
either the 1000 Genomes Project [14] or the ESP5400
data of the National Heart, Lung, and Blood Institute
GO Exome Sequencing Project [15]; (iii) in case of mis-
sense variants, those predicted to be deleterious using
the programs of PolyPhen-2 [16], SIFT [17] and Muta-
tion Taster [18] and (iv) variants occurring in known
microcephaly-causing or microcephaly-associated genes
as well as in candidate genes selected on the basis of
known biological, physiological or functional relevance
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to microcephaly. However, no variants survived this
process of prioritisation.
Targeted sequencing of the noncoding RNU4ATAC gene
identified causal variants in II:2
After failing to detect any pathogenic lesion by karyotyp-
ing, chromosomal microarray analysis and WES, we
began to consider the potential involvement of noncod-
ing RNA genes in the aetiology of microcephaly. An
extensive literature research resulted in the recognition
of two such genes. The first was the miR-17-92a-1 clus-
ter host gene (MIR17HG; OMIM #609415). Large-scale
copy number variants that serve either to delete or du-
plicate the entire MIR17HG locus cause Feingold syn-
drome 2 (OMIM #614326), a rare autosomal dominant
disorder characterised by variable combinations of
microcephaly, limb malformations, oesophageal and
duodenal atresias and learning disability [19–26]. Al-
though the disease entity under study here is most
consistent with a model of autosomal recessive inherit-
ance, we nevertheless revisited our chromosomal micro-
array analysis data and confirmed the absence of large
deletions or duplications involving the MIR17HG locus.
The second noncoding gene emerging from our litera-
ture search was RNU4ATAC, in which homozygous or
compound heterozygous variants have been reported to
cause microcephalic osteodysplastic primordial dwarfism
type-1 (MOPD1; OMIM #210710) in two simultaneous
papers in 2011 [27, 28]. MOPD1, also known as Taybi-
Linder syndrome [29], is a severe autosomal recessive
disease characterised by dwarfism, microcephaly and
neurologic abnormalities; patients usually die within the
first year of life [30]. RNU4ATAC is located on chromo-
some 2q14.2 and encodes the highly conserved, 130-bp
small nuclear RNA (snRNA) U4atac (RefSeq
NR_023343.1). U4atac is a component of the minor spli-
ceosome that is responsible for the correct splicing of
the U12-dependent class of introns [31–35]. To date, a
Fig. 1 Identification of the genetic cause of severe microcephaly in a Chinese family. a Family pedigree. Filled triangles with oblique lines indicate the
two successive foetuses affected with severe microcephaly and terminated by therapeutic abortion. Arrow indicates the proband. Open symbols indicate
clinically unaffected family members. Genotypes with respect to the RNU4ATAC gene are also provided where it was possible to determine them. wt,
wild-type. b U4atac snRNA secondary structure elements, evolutionary conservation status of each nucleotide position and MOPD1-causative SNVs
(adapted from [46]). The novel variant found in the present study, 29T>C, is highlighted in red and boxed. For a detailed description of the structure and
function of U4atac, see Merico et al. [46] and references therein
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Table 1 Clinical data of the two affected foetuses
Case Foetus 1 (II:1) Foetus 2 (II:2)
Growth (GW) 24 33 36 24 26 29
BPD (SD) − 6.0 − 6.0 − 6.1 − 4.4 − 5.6 − 6.0
HC (SD) − 4.0 − 5.6 − 7.5 − 3.7 − 4.2 − 5.5
FL (SD) − 2.0 − 1.6 − 2.0 0 − 1.0 0
HL (SD) − 1.5 / − 1.0 0 0 0
AC (SD) / − 2.4 − 3.8 − 0.7 − 1.0 − 1.4
Weight / 1.047 ± 0.153 kg (29 GW, < 50 centile)
Brain anomalies
Hypogenesis or agenesis of corpus callosum – –
Absence of septum pellucidum cavity – +
Intracranial cysts + +
Small vermis – –
Skeletal anomalies
Short limb + (slightly short) –
Flexion contractures – –
Cardiac abnormalities – –
Skin and skin appendage / /
BPD biparietal diameter, HC head circumference, FL femur length, HL humerus length, AC abdomen circumference, GW gestational week, SD standard deviation, /
not evaluable, − negative, + positive
Fig. 2 Ultrasound images of the three foetuses. a Biparietal diameter (BPD) and head circumference (HC) of foetus II:1 measured at 35 GW indicating
severe microcephaly. b Cross-section plane of the skull displaying arachnoid cysts (arrow) in foetus II:1. c–f Ultrasound images of foetus II:2: BPD and HC
measured at 29 GW indicating severe microcephaly (d); cross-section and three-dimensional sagittal plane of the skull showing the absence of the
septum pellucidum cavity (arrow; c), presence of intracranial cyst (arrows; e, f) and agenesis of corpus callosum (arrow; f). g, h Ultrasound images of the
healthy foetus II:3: BPD and HC (measured at 21 GW) shown in cross-section plane (g) and three-dimensional rebuilt imaging for foetus face (h)
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total of 12 RNU4ATAC variants including 11 SNVs (i.e.
30G>A, 40C>T, 46G>A, 50G>A, 50G>C, 51G>A,
53C>G, 55G>A, 66G>C, 111G>A and 124G>A) and 1
duplication variant (i.e. 16_100dup) have been reported
to be causative for MOPD1 [27, 28, 36–41]. Six of the
11 SNVs (i.e. 30G>A, 50G>A, 50G>C, 51G>A, 53C>G
and 55G>A) occurred within the critical canonical stem
region (i.e. 28–33, 50–55) of a functionally indispensable
element of U4atac, the 5′ stem-loop structure (Fig. 1b).
In what follows, we shall term this critical canonical
stem region the mutational hotspot region for MOPD1-
causative variants.
We, therefore, speculated that variants in the RNU4A-
TAC gene, which would not have been detected by
WES, might underlie the severe microcephaly in this
family. Subsequent targeted testing of the RNU4ATAC
gene by Sanger sequencing identified compound hetero-
zygous variants, 29T>C (rs779143800) and 51G>A
(rs188343279), in II:2. Carrier analysis confirmed that
the two variants had been inherited from the mother
and father, respectively (Fig. 1a). Although it was sus-
pected that the affected foetus II:1 had also inherited
these two variants, this could not be confirmed due to
the non-availability of genetic material.
51G>A was among the first described MOPD1-
causative variants [27, 28] and represents the most
common MOPD1-causative variant so far reported.
By contrast, 29T>C has not been previously reported
in MOPD1 patients. It has however been reported at
a very low frequency in normal populations; thus, it
is present in heterozygous form in two individuals in
the Genome Aggregation Database [42], correspond-
ing to an allele frequency of 1.6 × 10− 5. Further, in
common with all 11 previously reported MOPD1-
causative RNU4ATAC SNVs, 29T>C affected one of
the evolutionarily highly conserved positions of
U4atac (Fig. 1b). Furthermore, and most importantly,
29T is located within the mutational hotspot region
for MOPD1-causative variants (Fig. 1b). In this latter
regard, our current understanding of the pathogenetic
mechanism underlying the six known MOPD1-
causing RNU4ATAC SNVs occurring within the muta-
tional hotspot is that they abrogate U4atac snRNA
function by disrupting the 5′ stem-loop structure [27,
28, 41]. Accordingly, we compared the potential effect
of 29T>C on the 5′ stem-loop structure of U4atac
with those of the aforementioned six known MOPD1-
causative SNVs. To this end, wild-type and the seven
mutant sequences spanning positions 20 to 58 (i.e.
the sequence forming the 5′ stem-loop structure;
Fig. 1b) of U4atac were separately subjected to Mfold
analysis [43] under default conditions. All seven SNVs
were predicted to significantly affect the 5′ stem-loop
structure of U4atac as compared with the wild-type.
In particular, 29T>C was predicted to alter the sec-
ondary structure in the same way as the pathogenic
nucleotide substitutions 30G>A, 50G>A and 53C>G;
it was also predicted to alter the secondary structure
in a similar way to the most common pathogenic
51G>A variant (Fig. 3). These observations, taken to-
gether, strongly suggest that 29T>C constitutes a
novel causative variant for MOPD1.
Prenatal diagnosis of the third pregnancy
Prenatal diagnosis was performed on the third foetus (II:3)
(Fig. 1a). Genomic DNA was prepared from amniotic fluid
cells taken by ultrasound-mediated amniocentesis at 16
GW. However, neither the RNU4ATAC 51G>A variant
nor the 29T>C variant was detected. Normal foetal
growth was confirmed by continual ultrasound monitor-
ing during the whole period of pregnancy (Fig. 2g, h). The
third foetus was born healthy after 40 GW.
Discussion
In this study, we relate our experience of how the gen-
etic cause was finally identified in a Chinese family pre-
senting with two successive foetuses with severe
microcephaly. In brief, negative findings from karyotyp-
ing, chromosomal microarray analysis and WES in
foetus II:2 prompted us to consider the potential role of
noncoding genes in causing microcephaly in the family.
Consequently, targeted sequencing of the noncoding
RNU4ATAC gene resulted in the identification of com-
pound heterozygous variants, one being the most fre-
quently reported MOPD1-causative 51G>A, the other
being a novel 29T>A variant. Based upon the four lines
of evidence, namely allele frequency in normal popula-
tions, evolutionary conservation, occurrence within a
known mutational hotspot for MOPD1-causative vari-
ants and predicted effect on the 5′ stem-loop structure,
we were able to conclude with confidence that the newly
found 29T>A variant represents a new causative variant
for MOPD1. Here, we should like to make two add-
itional points. First, in the context of in silico analysis,
many algorithms have been designed to predict the func-
tional consequences of intronic or missense variants
found in protein-coding genes. However, these tools are
inappropriate for use with the RNU4ATAC variants dis-
cussed here, whose functional consequences depend
upon their potential effect on RNA secondary structure.
Currently, Mfold analysis is the gold standard for per-
forming RNA secondary structure predictions. Second,
stringent standards and guidelines have been proposed
for investigating the causality of sequence variants in hu-
man genetic disease [44, 45]. Apart from the aforemen-
tioned four lines of evidence supporting causality of the
detected compound heterozygous RNU4ATAC variants,
we would like to add a new consideration. The genomic
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structure of RNU4ATAC is very simple, comprising only
130 nucleotides. All the so far reported MOPD1-
causative RNU4ATAC variants were invariably located
within the 130 nucleotides.
Most previous studies have reported homozygous or
compound heterozygous RNU4ATAC variants in patients
with a diagnosis, or suggestive diagnosis, of MOPD1 [27,
28, 36–40]. Only very recently have RNU4ATAC variants
been described in foetuses [41]; all four foetuses (two of
whom were twins) had severe microcephaly together
with some other brain and skeletal abnormalities includ-
ing corpus callosum agenesis, short limb, brachydactyly
and ossification delay, suggestive of a diagnosis of
MOPD1. By contrast, the two foetuses in the family
under study here showed only severe microcephaly and
corpus callosum agenesis. The identification of com-
pound heterozygous RNU4ATAC variants in II:2, there-
fore, provided a definite diagnosis of the disease that
could not otherwise have been made merely on the basis
of clinical findings.
In a more general context, our study adds to the in-
creasing appreciation that variants in noncoding RNA
genes are an underestimated cause of human inherited
disease. Here, we further emphasise this point by citing
a recent finding concerning the RNU4ATAC gene. Com-
pound heterozygous RNU4ATAC variants have also been
reported to cause Roifman syndrome (OMIM #300258)
[10, 46], a rare congenital association of antibody defi-
ciency, spondyloepiphyseal chondro-osseous dysplasia,
retinal dystrophy, poor pre- and postnatal growth and
cognitive delay, which is phenotypically quite different
from MOPD1. It should be noted that Roifman
syndrome-causative compound heterozygous RNU4A-
TAC variants comprise one variant that is located within
MOPD1-implicated structural elements and one variant
that is located outside of MOPD1-implicated structural
elements [10, 46].
Conclusions
In a general context, our findings highlight one key
limitation of WES, namely that it fails to detect
disease causative variants within noncoding RNA
genes. This provides support for a role for whole-
genome sequencing as a first-tier genetic test in
paediatric medicine [9]. This is also the first report of
MOPD1-causative RNU4ATAC variants in the Chinese
population and the first report of prenatal diagnosis
and genetic counselling provided for a subsequent
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Fig. 3 Predicted effects of 29T>C, 30G>A, 50G>A, 51G>A and 53C>G on the 5′ stem-loop structure of U4atac. Secondary structures of the wild-type and
corresponding mutant sequences between positions 20 and 58 of U4atac (see Fig. 2b) were predicted by Mfold under default parameters, with the lowest
energy structures being shown. In the wild-type panel, the solid-boxed area indicates the canonical stem of the 5′ stem-loop structure in accordance with
[53, 54]; the dotted-boxed area indicates the mutational hotspot region for MOPD1-causative variants; all six known MOPD1-causative SNVs as well as the
newly found 29T>C variant occurring within the mutational hotspot region are also indicated. In the mutant panels, the respective variants are indicated
by arrows
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pregnancy once RNU4ATAC variants had been identi-
fied as a cause of MOPD1. Finally, the identification
of a novel RNU4ATAC variant within the mutational
hotspot for MOPD1-causative variants further
strengthens the critical role of the 5′ stem-loop struc-
ture of U4atac in health and disease.
Methods
Karyotyping and chromosomal microarray analysis
Standard G-banding karyotyping was performed. The
array experiments were performed using the high-
resolution Affymetrix CytoScan HD microarray (Affyme-
trix Inc., Santa Clara, CA) in accordance with the manu-
facturer’s protocols. The results were analysed using the
Chromosome Analysis Suite software version 1.2.2; the
reporting threshold of the copy number was set at 10 kb,
with marker count at ≥ 50, as previously reported [47].
WES
Genomic DNA was fragmented randomly and then purified
by means of the magnetic particle method. Sequences were
captured by Agilent SureSelect version 4 (Agilent Tech-
nologies, Santa Clara, CA) according to the manufacturer’s
protocols. The DNA libraries, after enrichment and purifi-
cation, were sequenced on the NextSeq500 sequencer ac-
cording to the manufacturer’s instructions (Illumina, San
Diego). The sequencing reads were aligned to GRCh37.p10
using Burrows-Wheeler Aligner software (version 0.59)
[48]. Local realignment and base quality recalibration of the
Burrows-Wheeler aligned reads were then performed using
the GATK IndelRealigner [49] and GATK BaseRecalibrator
[50], respectively. SNVs and small indels were identified by
the GATK UnifiedGenotyper [51]. Variants were annotated
using the Consensus Coding Sequences Database at the
National Centre for Biotechnology Information [52].
Targeted sequencing of the RNU4ATAC gene
Primer sequences and PCR conditions are available upon
request.
RNA secondary structure prediction
This was performed by means of Mfold analysis under
default conditions [43].
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